• Mashup Score: 0

    About this Tool This clinical decision support tool (CDST) is designed to assist clinicians in selecting cytomegalovirus (CMV) therapy for solid organ transplant (SOT) patients (lung, heart, liver, kidney, pancreas, or intestine) or hematopoietic cell transplant (HCT) patients 12 years or older with suspected or confirmed antiviral resistant or refractory CMV infection or disease. The definitions…

    Tweet Tweets with this article
    • Have you used the Clinical Decision Support Tool (CDST)? This novel tool will help you select optimal treatment for SOT or HCT patients with CMV infection or disease. Learn more šŸ‘‰ https://t.co/l2gVGFaDHn #TransplantTwitter #SolidOrganTransplant #tools https://t.co/GExo7EknFF